Sanofi-Aventis

Sanofi announces results of first Phase III dengue vaccine in The Lancet

14 Jul 2014

Sanofi unit Genzyme in alliance with Alnylam Pharmaceuticals to develop RNAi therapeutics

13 Jan 2014

Sanofi fails to win US FDA approval for Genzyme's MS drug Lemtrada

30 Dec 2013

The drug, which gained approval in the EU in September, and in Australia and Canada this month, formed a key part of Sanofi’s $20.1-billion acquisition of Genzyme in 2011

Sanofi, Shire eye US rare diseases drug maker ViroPharma

14 Sep 2013

Sanofi becomes latest drug firm under Chinese probe for bribery

12 Aug 2013

Andhra HC quashes tax demand on Sanofi over Shantha Biotech buyout

15 Feb 2013

INDOX expansion boosts cancer research across India

04 Feb 2013

Sanofi still in the race for Bayer’ blood glusose testing business: report

08 Dec 2012

Sanofi to acquire Colombian affordable drugmaker Genfar

03 Oct 2012

Sanofi to eliminate 900 R&D jobs in France

26 Sep 2012

Sanofi to acquire US medical device company Pluromed to expand in biosurgery

16 Mar 2012

Lupin, Sanofi-Aventis Philippines in strategic agreement

05 Sep 2011

Sanofi plans Rs450-cr OTC deal with Universal Medicare

23 Aug 2011

Sanofi to sell skincare business to Canada's Valeant Pharmaceuticals for $425 mn

11 Jul 2011

Sanofi-Aventis shortens name to Sanofi

07 May 2011

Merck, Sanofi Pasteur start Phase-3 trials of paediatric combination vaccine in US

23 Apr 2011

Sanofi-Aventis, Genzyme in talks to structure $80 per share deal

08 Jan 2011

Sanofi-Aventis extends Genzyme offer, terms unchanged

13 Dec 2010

Aventis to exit Chiron JV with Novartis, with Rs105-crore stake sale

13 Dec 2010

Sanofi-Aventis goes hostile with $18.5-bn Genzyme bid

04 Oct 2010

Refusing to hike its offer French pharmaceutical giant Sanofi-Aventis today went hostile with its $18.5-billion takeover bid for the world's third-largest biotech firm, Genzyme Corporation

Sanofi Aventis reportedly raises offer to $71 per share

09 Sep 2010

Genzyme board rejects Sanofi-Aventis $18.5-billion takeover offer

31 Aug 2010

Sanofi-Aventis reveals $18.5-billion offer for Genzyme

30 Aug 2010

Genzyme begins takeover talks with Sanofi-Aventis

03 Aug 2010

Glaxo follows Sanofi-Aventis to biotech major Genzyme

26 Jul 2010